GEMCITABINE HYDROCHLORIDE (Accord Healthcare Inc.)
Welcome to the PulseAid listing for the GEMCITABINE HYDROCHLORIDE drug offered from Accord Healthcare Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Accord Healthcare Inc. |
NON-PROPRIETARY NAME: | Gemcitabine hydrochloride |
SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-07-28 |
END MARKETING DATE: | 0000-00-00 |
GEMCITABINE HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | GEMCITABINE HYDROCHLORIDE from Accord Healthcare Inc. |
LABELER NAME: | Accord Healthcare Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/5mL) |
START MARKETING DATE: | 2011-07-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16729-092_3d320325-0b88-4a83-e054-00144ff8d46c |
PRODUCT NDC: | 16729-092 |
APPLICATION NUMBER: | ANDA091594 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: